Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 6367 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
  My preferences 


This article has been cited by
1Prescribing of psychotropic medication for personality disordered patients in secure forensic settings
Birgit A. Völlm,Karen Chadwick,Tarek Abdelrazek,Julie Smith
The Journal of Forensic Psychiatry & Psychology.2012;23(2)200
2Effect of clozapine on rates of risk incidents and functioning in female adolescents with a diagnosis of severe emerging emotionally unstable personality disorder
Oliver White,Simon A. Hill,Rebekka Coleman,Enys Delmage
The Journal of Forensic Psychiatry & Psychology.2017;28(6)737
3Use of Clozapine for Borderline Personality Disorder: A Case Report
Badii Amamou,Walid Bel Hadj Salah,Ahmed Mhalla,Nejla Benzarti,Hend Elloumi,Ferid Zaafrane,Lotfi Gaha
Clinical Psychopharmacology and Neuroscience.2016;14(2)226
4Clozapine for self-injurious behavior in individuals with borderline personality disorder
Theodore Zarzar,Joseph McEvoy
Therapeutic Advances in Psychopharmacology.2013;3(5)272
5Clozapine: an effective treatment for seriously violent and psychopathic men with antisocial personality disorder in a UK high-security hospital
Darcy Brown,Fintan Larkin,Samrat Sengupta,Jose L. Romero-Ureclay,Callum C. Ross,Nitin Gupta,Morris Vinestock,Mrigendra Das
CNS Spectrums.2014;19(5)391
6Borderline Personality Disorder and Depression: An Update
Maria Luca,Antonina Luca,Carmela Calandra
Psychiatric Quarterly.2012;83(3)281
7Clozapine use in women with borderline personality disorder and co-morbid learning disability
Tolulope Fajumi,Maryam Manzoor,Katie Carpenter
Journal of Learning Disabilities and Offending Behaviour.2012;3(1)6
8The novel use of clozapine in an adolescent with borderline personality disorder
Sarah Elizabeth Argent,Simon Alastair Hill
Therapeutic Advances in Psychopharmacology.2014;4(4)149